Company intelligence / Profile preview

LumaBio

Ownership: Private
Development stage: Commercial

Overview

Luma Bio markets over-the-counter red and near-infrared light therapy devices cleared by the US FDA and Indian CDSCO for temporary relief of minor muscle/joint/arthritis pain, muscle spasms, increased local blood flow, and relaxation. Devices are intended for home or commercial use. No clinical trial results reported; clearance is based on device safety/effectiveness as per regulatory standards.

Therapeutic areas: CardiovascularRheumatologyNeurology
Modalities: DeviceNon-pharmacological therapyLight-based therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on LumaBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LumaBio.

Explore the full profile